D
Live / Registered — Registered (as of 01 Sept 2026)
What this means for you
Registered since 01 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 97229686
- Registration number
- 8418539
- Mark type
- Design + words
- Filed
- 20 Jan 2022
- Published for opposition
- 14 Jul 2026
- Registered
- 01 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 01 Sept 2032 (grace period to 01 Mar 2033)
- Attorney of record
- Gary P. Oakeson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical products for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical preparations for the treatment of mental conditions, illnesses, and disorders; pharmaceutical drugs for the treatment of mental conditions, illnesses, and disorders; psychedelic pharmaceuticals for the treatment of central nervous system conditions, illnesses, and disorders; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; serotonin receptor agonists and antagonist pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; drug abuse deterrent products in the nature of low-dose pharmaceutical preparations and products, very low-dose pharmaceutical preparations and products, extended release pharmaceutical preparations and products, and tamper resistant pharmaceutical preparations and products; pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, and/or behavior; pharmaceutical preparations for use in psychedelic therapies for the treatment of mental health disorders;
- Class 009 — Scientific and electric apparatus: Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer software applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical systems comprising recorded and downloadable software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical alert response systems comprising recorded and downloadable software and/or hardware for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a Medical Device (SaMD) for stimulating nerves
- Class 010 — Medical apparatus: Electroencephalogram (EEG) devices, namely, electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of pharmaceuticals; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices for use in therapy of cognitive states, namely, to monitor, sense, or measure cognitive impairment during use of pharmaceuticals; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively, namely, comprising a sensor for monitoring and measuring brain and neural activity; medical device used in combination with pharmaceutical preparations for treating of mental health disorders non-invasively, namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity
- Class 035 — Advertising and business services: Wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses and disorders
- Class 040 — Treatment of materials: Custom manufacture for others of pharmaceuticals, pharmaceutical drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture for others of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to treat mental conditions, illnesses and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery services; consultancy pertaining to pharmacology; medical research in the field of mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services, including pre-clinical and clinical pharmaceutical drug development; pharmaceutical drug development and discovery relating to new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms
- Class 045 — Legal and security services: Licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses, and disorders
Owner
- Diamond Therapeutics Inc., Toronto, CA
- Diamond Therapeutics Inc., Toronto, CA
- Diamond Therapeutics Inc., Toronto, CA
Prosecution history
- 01 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
- 12 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
- 12 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
- 15 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 May 2026 — NON-FINAL ACTION E-MAILED